Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.360
-0.090 (-6.21%)
At close: Dec 20, 2024, 4:00 PM
1.470
+0.110 (8.09%)
After-hours: Dec 20, 2024, 7:25 PM EST
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $26.27 million as of December 20, 2024. Its market cap has decreased by -68.05% in one year.
Market Cap
26.27M
Enterprise Value
33.39M
1-Year Change
-68.05%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $26.27M, a decrease of -90.41%. That is a compound annual growth rate of -52.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 26.27M | -50.94% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IGC Pharma | 28.50M |
| IRIDEX | 28.45M |
| RAPT Therapeutics | 28.24M |
| CytoMed Therapeutics | 28.16M |
| KALA BIO | 27.66M |
| RenovoRx | 27.58M |
| Forte Biosciences | 27.28M |
| BriaCell Therapeutics | 26.85M |